Trial Profile
Efficacy of ramosetron hydrochloride in male patients with diarrhea-predominant irritable bowel syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary) ; Polycarbophil calcium
- Indications Irritable bowel syndrome
- Focus Expanded access; Therapeutic Use
- 16 Nov 2011 New trial record